Download PDF
CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2016; 04(02): 067-070
DOI: 10.4103/2321-0656.187990
Review Article
NovoNordisk Education Foundation

Expanding the definition of noncommunicable disease

Ranabir Salam
Department of General Medicine, Regional Institute of Medical Sciences, Imphal, Manipur, India
› Author Affiliations
Further Information

Publication History

Publication Date:
23 November 2018 (online)

Also available at
   Permissions and Reprints

Abstract

Noncommunicable diseases (NCDs) are responsible for 68% of all deaths in 2012. Eighty-two percent of these “premature” deaths occurred in low- and middle-income countries. Most of the NCD deaths are caused by cardiovascular diseases, cancer, diabetes, chronic respiratory diseases, mental health, road traffic accidents, and violence. The World Health Organization, several governments, and nongovernmental organizations have taken up numerous programs to curb the menace of NCDs. However, the present programs do not include some common chronic medical conditions which also lead to considerable morbidity and mortality. The present review highlights three important chronic disorders: chronic kidney disease (CKD), liver disease (cirrhosis and nonalcoholic fatty liver), and thyroid diseases. CKD is an internationally recognized public health problem affecting 5–10% of the world population. CKD resulted in 956,000 deaths in 2013 and proposes them to be included in the world wide accepted definition of NCD. Cirrhosis and chronic liver disease were the tenth leading cause of death for men and the twelfth for women in the United States in 2001. Moreover, 4–10% of the global population have thyroid dysfunction. This mini-review proposes to expand the definition of NCD to include these three major illnesses.

Chronic kidney disease - nonalcoholic fatty liver - noncommunicable disease - thyroid disease
 

  • References

  • 1 Noncommunicable Diseases. WHO Fact Sheet: Updated; January, 2015. Available from: http://www.who.int/mediacentre/factsheets/fs355/en/ [Last accessed on 2016 Jun 27].
    Google Scholar
  • 2 Non-communicable diseases deemed development challenge of ‘Epidemic Proportions’ in political declaration adopted during landmark general assembly summit. New York: United Nations: Department of Public Information; 2011. Available from: http://www.un.org/en/ga/ncdmeeting2011/
    Google Scholar
  • 3 The Top 10 Causes of Death. World Health Organization. Available from: www.who.int/mediacentre/factsheets/fs310/en [Last accessed on 2016 Jun 27].
    Google Scholar
  • 4 Noncommunicable Diseasese. World Health Organization. Available from: www.who.int/mediacentre/factsheets/fs355/en/ [Last accessed on 2016 Jun 27].
    Google Scholar
  • 5 Global noncommunicable diseases. Saving lives by reducing risk. Centers for Disease Control and Prevention (CDC); 20 April, 2016. Available from: www.cdc.gov/globalhealth/healthprotection/ncd/ [Last Accessed on 2016 Jul 02].
    Google Scholar
  • 6 Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012; 380: 2224-2260
    CrossrefPubMedGoogle Scholar
  • 7 Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE. et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med 2014; 371: 624-634
    CrossrefPubMedGoogle Scholar
  • 8 World Health Organization. Non-communicable Diseases Country Profile; 2011. Available from: www.who.int/nmh/publications/ncd_profiles2011/en/ [Last accessed on 2016 Jun 27].
    Google Scholar
  • 9 Mahal A, Karan A, Engelgau M. The economic implications of non-communicable disease for India. Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2009: xiv
    Google Scholar
  • 10 ICMR-MRC Workshop. Building Indo-UK Collaboration in Chronic Diseases. 2009: 16
    Google Scholar
  • 11 Preventing Chronic Diseases a Vital Investment. Geneva: Cataloguing-in-Publication Data (World Health Organization); 2005: 1
    Google Scholar
  • 12 Srinath Reddy K, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India. Lancet 2005; 366: 1744-1749
    CrossrefPubMedGoogle Scholar
  • 13 World Health Organization. Chronic Disease Report; 2005. Prakash R. Upadhay from AIIMS, New Delhi published in Iranian J Publ Health 2012; 41: 1-8
    Google Scholar
  • 14 Prevention and Control of Non Communicable Diseases. Ministry of Health & Family Welfare-Government of India. Available from: http://www.mohfw.nic.in [Last accessed on 2016 Jul 02].
    Google Scholar
  • 15 Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N. et al. The burden of kidney disease: Improving global outcomes. Kidney Int 2004; 66: 1310-1314
    CrossrefPubMedGoogle Scholar
  • 16 Martínez-Castelao A, Górriz JL, Segura-de la Morena J, Cebollada J, Escalada J, Esmatjes E. et al. Consensus document for the detection and management of chronic kidney disease. Nefrologia 2014; 34: 243-262
    PubMedGoogle Scholar
  • 17 GBD Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the global burden of disease study 2013. Lancet 2015; 385: 117-171
    CrossrefPubMedGoogle Scholar
  • 18 Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M. et al. Guidelines for the management of chronic kidney disease. CMAJ 2008; 179: 1154-1162
    CrossrefPubMedGoogle Scholar
  • 19 Centers for Disease Control and Prevention (CDC). Prevalence of chronic kidney disease and associated risk factors – United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2007; 56: 161-165
    PubMedGoogle Scholar
  • 20 Morgan T. Chronic kidney disease (stages 3–5) prevalence estimates using data from the Neoerica study (2007). England: Association of Public Health Observatories; 2009
    Google Scholar
  • 21 Agarwal SK, Dash SC, Irshad M, Raju S, Singh R, Pandey RM. Prevalence of chronic renal failure in adults in Delhi, India. Nephrol Dial Transplant 2005; 20: 1638-1642
    CrossrefPubMedGoogle Scholar
  • 22 Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health 2008; 8: 117
    CrossrefPubMedGoogle Scholar
  • 23 Anderson RN, Smith BL. Deaths: Leading causes for 2001. Natl Vital Stat Rep 2003; 52: 1-85
    PubMedGoogle Scholar
  • 24 Sørensen HT, Thulstrup AM, Mellemkjar L, Jepsen P, Christensen E, Olsen JH. et al. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: A nationwide cohort study in Denmark. J Clin Epidemiol 2003; 56: 88-93
    CrossrefPubMedGoogle Scholar
  • 25 Shaker M, Tabbaa A, Albeldawi M, Alkhouri N. Liver transplantation for nonalcoholic fatty liver disease: New challenges and new opportunities. World J Gastroenterol 2014; 20: 5320-5330
    CrossrefPubMedGoogle Scholar
  • 26 Rinella ME. Nonalcoholic fatty liver disease: A systematic review. JAMA 2015; 313: 2263-2273
    CrossrefPubMedGoogle Scholar
  • 27 Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Bethesda, MD: American Gastroenterological Association; 2002
    Google Scholar
  • 28 Ruhl CE, Everhart JE. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol Ther 2015; 41: 65-76
    CrossrefPubMedGoogle Scholar
  • 29 Omagari K, Kadokawa Y, Masuda J, Egawa I, Sawa T, Hazama H. et al. Fatty liver in non-alcoholic non-overweight Japanese adults: Incidence and clinical characteristics. J Gastroenterol Hepatol 2002; 17: 1098-1105
    CrossrefPubMedGoogle Scholar
  • 30 Hilden M, Christoffersen P, Juhl E, Dalgaard JB. Liver histology in a 'normal' population – Examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 1977; 12: 593-597
    CrossrefPubMedGoogle Scholar
  • 31 Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH. et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: An epidemiological survey. World J Gastroenterol 2003; 9: 1106-1110
    CrossrefPubMedGoogle Scholar
  • 32 Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E. et al. Non-alcoholic fatty liver disease and mortality among US adults: Prospective cohort study. BMJ 2011; 343: d6891
    CrossrefPubMedGoogle Scholar
  • 33 Clark JM, Diehl AM. Nonalcoholic fatty liver disease: An underrecognized cause of cryptogenic cirrhosis. JAMA 2003; 289: 3000-3004
    CrossrefPubMedGoogle Scholar
  • 34 McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004; 8: 521-533 viii.
    CrossrefPubMedGoogle Scholar
  • 35 Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR. et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 2010; 51: 1593-1602
    CrossrefPubMedGoogle Scholar
  • 36 Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban South Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract 2009; 84: 84-91
    CrossrefPubMedGoogle Scholar
  • 37 Ingle M, Abraham P. Epidemiology of non-alcoholic fatty liver disease in Asia. Non-alcoholic fatty liver disease: A clinical spectrum. In: Choudhuri G. ECAB Clinical Update: Gastroenterology/Hepatology. New Delhi: Elsevier; 2013: 18-28
    Google Scholar
  • 38 Usha Menon V, Sundaram KR, Unnikrishnan AG, Jayakumar RV, Nair V, Kumar H. High prevalence of undetected thyroid disorders in an iodine sufficient adult South Indian population. J Indian Med Assoc 2009; 107: 72-77
    PubMedGoogle Scholar
  • 39 Marwaha RK, Tandon N, Karak AK, Gupta N, Verma K, Kochupillai N. Hashimoto's thyroiditis: Countrywide screening of goitrous healthy young girls in postiodization phase in India. J Clin Endocrinol Metab 2000; 85: 3798-3802
    PubMedGoogle Scholar
  • 40 Hollowell JH, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA. et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499
    CrossrefPubMedGoogle Scholar
  • 41 Olsen AH, Kelsberg G, Coffey J, Hsu JT. Clinical inquiries. Should we screen women for hypothyroidism?. J Fam Pract 2004; 53: 653-655
    Google Scholar
  • 42 Demitrost L, Ranabir S. Thyroid dysfunction in type 2 diabetes mellitus: A retrospective study. Indian J Endocrinol Metab 2012; 16 (Suppl. 02) S334-S335
    PubMedGoogle Scholar
  • 43 Brenta G. Diabetes and thyroid disorders. Br J Diabetes Vasc Dis 2010; 10: 172-177
    CrossrefGoogle Scholar
  • 44 Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf) 2011; 75: 1-9
    CrossrefPubMedGoogle Scholar